Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer

INTRODUCTION: Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Einefors, Rickard, Kogler, Ulrika, Ellberg, Carolina, Olsson, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755812/
https://www.ncbi.nlm.nih.gov/pubmed/24010029
http://dx.doi.org/10.1186/2193-1801-2-357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755812/
https://www.ncbi.nlm.nih.gov/pubmed/24010029
http://dx.doi.org/10.1186/2193-1801-2-357

Ejemplares similares